Public data, as of October 2026

Company profile

AstraZeneca plc

AZNastrazeneca.comLatest disclosure 2024

AstraZeneca plc reported about 6 million tCO₂e for 2024, and 98% of it sits in Scope 3, in the value chain beyond the company's own operations.

Is this your company? Claim it

SBTi statusValidated Targets

Near-term status: Validated Targets. Net-zero status: Validated Targets.

Where insetting fits

Scope 3 is 98% of the footprint, the part of the value chain that supplier emissions reductions can reach.

Peer position

Scope 3 is 98% of the footprint, above the peer median of 91%.

Voluntary retirements

Registry records show 1 credits retired for this company.

Emissions

How the reported footprint breaks down by scope and year.

tCO₂e, GHG Protocol scopes
Source: published disclosure, FY2024

Peer benchmark

How AstraZeneca plc compares with its industry peers on Scope 3.

Peers: companies in the SBTi industry "Pharmaceuticals, Biotechnology and Life Sciences", by Scope 3 share of the latest reported footprint.

CompanyScope 3 share%

AstraZeneca plcThis company98%
McKesson Corporation99%

Company profile

A claimed profile keeps the figures accurate and shows the company’s projects.

Claiming is free. Your team can correct data, add newer disclosures and list reduction projects from your value chain, so that customers and suppliers can co-fund them.

Claim this profile Talk to Carbon3

1
Confirm employment at the company

Related projects

None yet

Inset projects on Carbon3None yet

Reported emissions by year

Scope 1
Scope 2
Scope 3

FY2024

Scope 1, direct	125,3862%
Scope 2, purchased energy	14,210<1%
Scope 3, value chain	5,897,82298%
Total	6,037,418

Years without a matched disclosure stay open until a published source is matched.

Source document: astrazeneca.com

Scope 3 by category, 2024

12 categories itemized

C1Purchased Goods and ServicesLargest category3.8 Mt64%
C2Capital Goods66 kt1%
C3Fuel and Energy Related Activities48 kt1%
C4Upstream Transportation and Distribution235 kt4%
C5Waste Generated in Operations24 kt<1%
C6Business Travel190 kt3%
C7Employee Commuting51 kt1%
C8Upstream Leased Assets16 kt<1%
C9Downstream Transportation and Distribution121 kt2%
C11Use of Sold Products1.4 Mt23%
C12End-of-Life Treatment of Sold Products16 kt<1%
C13Downstream Leased Assets2 kt<1%

Climate targets

What the SBTi listing says about the company's targets.

Status as published by the SBTi

Primary SBTi record: AstraZeneca

Near-term targetValidated Targets

Classification: 1.5°C
Target year: 2030

Net-zero targetValidated Targets

Net-zero year: 2045

Carbon3 shows each record exactly as the SBTi publishes it, and does not assess, rate or endorse targets. A validated target says nothing about any market instrument.

Voluntary retirements

Voluntary credits retired for this company on public registries.

Registry records naming the company as beneficiary

ProjectRegistryRetired inCredits retired

Hydropower (VCS513)Verra20251

These are voluntary market retirements, which sit outside the value chain. Inset credits retired on Carbon3 would appear as their own rows, linked to the supplier project.1 credits in total

Bayer Aktiengesellschaft

74%

Thermo Fisher Scientific Inc.94%

Merck & Co., Inc.87%

Merck KGaA81%

Roche Holding AG96%

Peer median: 91%Scope 3 boundaries differ between reports, so compare shares with care.

Scope 3 position

Above the peer median

The company's Scope 3 share is 98%, against a peer median of 91%.

Disclosure coverage

6 of 6 disclose

6 of 6 named peers report all three scopes, so their Scope 3 share can be compared.

Research summary

What the public record says about this company's decarbonization.

No report has been generated for this company yet

Anyone can read a cached company report, while generating a new one can take a few minutes and needs a free account.

Related projects

Decarbonization projects that name the company as a partner.

Emerging projects catalog, status as reported by each project

No projects linked to this company yet

Carbon3 has not yet found a public decarbonization project that names this company.

No inset projects are listed for this company yet.

Suppliers to AstraZeneca plc can list a reduction project on Carbon3 at no cost, so that the company could co-fund it.

List a supplier project

Sign in with an email address at the company's own domain.

2

Review the data

Flag corrections and upload newer disclosures, which Carbon3 checks against a published source.

3

List a project at no cost

Turn verified supply-chain reductions into inset credits that partners can co-fund.

A free account also gives access to downloads, alerts and new research reports.